In conclusion, SC-5 can protect mice from DSS-induced colitis by inhibiting the activation of NF-κB and MAPK signaling pathways, strengthening tight junction proteins, improving the integrity of the intestinal mucosal barrier, and restoring the balance of gut microbiota structure. Here, NFKB1 is linked to colitis.